Package | us.nlm.vsac |
Type | ValueSet |
Id | Id |
FHIR Version | R4 |
Source | http://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113883.3.464.1003.1150/expansion |
Url | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1150 |
Version | 20240124 |
Status | active |
Date | 2024-01-24T01:11:59-05:00 |
Name | SubstanceUseDisorderShortActingMedication |
Title | Substance Use Disorder Short Acting Medication |
Experimental | False |
Realm | us |
Authority | hl7 |
Purpose | (Clinical Focus: The purpose of this Grouping value set is to represent concepts for short acting substance use disorder medications.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent generic, human use and prescribable Acamprosate, Disulfiram, Naltrexone Oral, Buprenorphine Naloxone and Buprenorphine (oral, sublingual) medications.),(Exclusion Criteria: Excludes concepts that represent non-prescribable or branded drugs and excludes concepts that represent components or ingredients. Excludes long acting implant and injection medications.) |
No resources found
CodeSystem | |
http://www.nlm.nih.gov/research/umls/rxnorm | RxNorm |
http://www.nlm.nih.gov/research/umls/rxnorm | RxNorm |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1259 | Substance Use Disorder Short Acting Medication |
{
"resourceType" : "ValueSet",
"id" : "2.16.840.1.113883.3.464.1003.1150",
"meta" : {
"versionId" : "12",
"lastUpdated" : "2024-01-24T09:53:01.000-05:00",
"profile" : [
"http://hl7.org/fhir/StructureDefinition/shareablevalueset",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
]
},
"extension" : [
{
"url" : "http://hl7.org/fhir/StructureDefinition/valueset-author",
"valueContactDetail" : {
"name" : "NCQA PHEMUR Author"
}
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
"valueDate" : "2024-01-24"
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
"valueDate" : "2024-01-24"
}
],
"url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1150",
"identifier" : [
{
"system" : "urn:ietf:rfc:3986",
"value" : "urn:oid:2.16.840.1.113883.3.464.1003.1150"
}
],
"version" : "20240124",
"name" : "SubstanceUseDisorderShortActingMedication",
"title" : "Substance Use Disorder Short Acting Medication",
"status" : "active",
"date" : "2024-01-24T01:11:59-05:00",
"publisher" : "NCQA PHEMUR",
"jurisdiction" : [
{
"coding" : [
{
"system" : "urn:iso:std:iso:3166",
"code" : "US"
}
]
}
],
"purpose" : "(Clinical Focus: The purpose of this Grouping value set is to represent concepts for short acting substance use disorder medications.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent generic, human use and prescribable Acamprosate, Disulfiram, Naltrexone Oral, Buprenorphine Naloxone and Buprenorphine (oral, sublingual) medications.),(Exclusion Criteria: Excludes concepts that represent non-prescribable or branded drugs and excludes concepts that represent components or ingredients. Excludes long acting implant and injection medications.)",
"compose" : {
"include" : [
{
"valueSet" : [
"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1259"
]
}
]
},
"expansion" : {
"identifier" : "urn:uuid:03ebf3e4-9f93-4b3b-bcf0-58064c74bbc2",
"timestamp" : "2024-12-10T10:40:45-05:00",
"total" : 21,
"contains" : [
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1010600",
"display" : "buprenorphine 2 MG / naloxone 0.5 MG Sublingual Film"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1010604",
"display" : "buprenorphine 8 MG / naloxone 2 MG Sublingual Film"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1307056",
"display" : "buprenorphine 4 MG / naloxone 1 MG Sublingual Film"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1307061",
"display" : "buprenorphine 12 MG / naloxone 3 MG Sublingual Film"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1431076",
"display" : "buprenorphine 1.4 MG / naloxone 0.36 MG Sublingual Tablet"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1431102",
"display" : "buprenorphine 5.7 MG / naloxone 1.4 MG Sublingual Tablet"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1483744",
"display" : "naltrexone hydrochloride 50 MG Oral Tablet"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1542390",
"display" : "buprenorphine 2.1 MG / naloxone 0.3 MG Buccal Film"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1544851",
"display" : "buprenorphine 4.2 MG / naloxone 0.7 MG Buccal Film"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1544854",
"display" : "buprenorphine 6.3 MG / naloxone 1 MG Buccal Film"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1597568",
"display" : "buprenorphine 11.4 MG / naloxone 2.9 MG Sublingual Tablet"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1597573",
"display" : "buprenorphine 8.6 MG / naloxone 2.1 MG Sublingual Tablet"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1666338",
"display" : "buprenorphine 2.9 MG / naloxone 0.71 MG Sublingual Tablet"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1864412",
"display" : "buprenorphine 0.7 MG / naloxone 0.18 MG Sublingual Tablet"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "197623",
"display" : "disulfiram 250 MG Oral Tablet"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "197624",
"display" : "disulfiram 500 MG Oral Tablet"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "351264",
"display" : "buprenorphine 2 MG Sublingual Tablet"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "351265",
"display" : "buprenorphine 8 MG Sublingual Tablet"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "351266",
"display" : "buprenorphine 2 MG / naloxone 0.5 MG Sublingual Tablet"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "351267",
"display" : "buprenorphine 8 MG / naloxone 2 MG Sublingual Tablet"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "835726",
"display" : "acamprosate calcium 333 MG Delayed Release Oral Tablet"
}
]
},
"text" : {
}
}
XIG built as of ??metadata-date??. Found ??metadata-resources?? resources in ??metadata-packages?? packages.